Amyris Inc. (NASDAQ:AMRS) is Attracting Smart Money

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC),...
Stay Ahead of the
Stock Market Game!
Subscribe to Small Cap
Exclusive for more


Is TRVI is a good stock? It depends, is it a trendin...
Broadfin Capital is Buying Catalyst Pharmaceuticals ...
Here's Who Just Picked Up Depomed Inc. (NASDAQ:DEPO)...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Amyris Inc. (NASDAQ:AMRS) reported that Temasek Holdings (private) Ltd. has picked up 61,764,891 of common stock as of 2017-02-27.

The acquisition brings the aggregate amount owned by Temasek Holdings (private) Ltd. to a total of 61,764,891 representing a 22.1% stake in the company.

For those not familiar with the company, Amyris, Inc. is an integrated industrial biotechnology company. The Company is engaged in research and development and sales of fuels and farnesene-derived products. It is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including cosmetics, flavors and fragrances (F&F), solvents and cleaners, polymers, lubricants, healthcare products and fuels. The Company focuses on a renewable hydrocarbon molecule called farnesene (Biofene). The Company is expanding its range of products across various categories divided into consumer and industrial applications. For consumer applications, the Company is developing and selling personal care products (which include ingredients for cosmetics and F&F), healthcare products and formulated end user products, such as Biossance brand skincare products and Muck Daddy brand hand cleaner product.

A glance at Amyris Inc. (NASDAQ:AMRS)’s key stats reveals a current market capitalization of 140.76  million based on 273.83 Million shares outstanding and a price at last close of $0.523 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2016-06-14, Doerr picked up 200,577 at a purchase price of $1.04. This brings their total holding to 13,037,586 as of the date of the filing.

On the sell side, the most recent transaction saw Maxwell unload 254,570 shares at a sale price of $0.54. This brings their total holding to 56,812,277.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Amyris Inc. (NASDAQ:AMRS) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.



Stay in the lopp :

Is American Airlines Group Inc (NASDAQ:AAL) a...
TWO STOCKS GO UP 109% in Two Trading Days!

Click HERE To Receive Exclusive, PRIVATE-PREMIUM STOCK PICKS & Possibly $250 (Yes we’re bribing you)


Breakout for Mainz Biomed MYNZ?

Mainz Biomed MYNZ develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. So, our traders have the ability to invest and feel good

related post

Skip to content